Niro Ramachandran Ph.D. is Chief Business Officer at Akoya Biosciences, Inc. (AKYA). They have made 1 open-market trade across 1 company since 2021, most recently 2025-07-08.
CIK 0001857443
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $329K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AKYA | 324,703 | $419K |
Shares reported on the most recent Form 4, priced at the 2025-07-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKYA | BUY | 2021-11-19 | 2021-11-22 | $13.13 | $329K | -6.7% | +0.8% | -20.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.